Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.
about
Sox17 regulates insulin secretion in the normal and pathologic mouse β cellAltered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa)Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic isletsOverexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretionAssociation of dioxin and other persistent organic pollutants (POPs) with diabetes: epidemiological evidence and new mechanisms of beta cell dysfunctionIB1, a JIP-1-related nuclear protein present in insulin-secreting cellsIslet Hypersensitivity to Glucose Is Associated With Disrupted Oscillations and Increased Impact of Proinflammatory Cytokines in Islets From Diabetes-Prone Male Mice.Dysregulated pyruvate dehydrogenase complex in Zucker diabetic fatty rats.Fatty diabetic lung: altered alveolar structure and surfactant protein expressionGLUT-2 function in glucose-unresponsive beta cells of dexamethasone-induced diabetes in ratsThe loss of GLUT2 expression by glucose-unresponsive beta cells of db/db mice is reversible and is induced by the diabetic environment.Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes.Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats.Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships.Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.Engineering of glucose-stimulated insulin secretion and biosynthesis in non-islet cells.PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation.Regulation of fatty acid homeostasis in cells: novel role of leptin.Mechanisms of improved glucose handling after metabolic surgery: the big 6.The glucose transporter 2 undergoes plasma membrane endocytosis and lysosomal degradation in a secretagogue-dependent manner.Role of nitric oxide in obesity-induced beta cell disease.Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport.Early endocrine and molecular changes in metabolic syndrome models.Coming full circle in diabetes mellitus: from complications to initiation.Renal function and structure in diabetic, hypertensive, obese ZDFxSHHF-hybrid rats.Stevioside improves pancreatic beta-cell function during glucotoxicity via regulation of acetyl-CoA carboxylase.Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport.Non-insulin dependent diabetes mellitus: defects in insulin secretion.Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA.Cyanidin Stimulates Insulin Secretion and Pancreatic β-Cell Gene Expression through Activation of l-type Voltage-Dependent Ca2+ Channels.Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells.Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver.Phlorizin treatment prevents the decrease in plasma insulin levels but not the progressive histopathological changes in the pancreatic islets during aging of Zucker diabetic fatty rats.Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM.Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high-fat diet.Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats.Glucose Transport Activity Measured in Giant Vesicles.
P2860
Q27315224-5B547D5C-3C31-495B-A00F-88CF23A41CD9Q28325279-1A5E2B5D-861D-47E0-9360-E42DD19198B6Q28344493-6FECB626-15DD-4678-9EAA-2435BFF19320Q28368982-533AB590-D61B-4A0C-A4EC-1FDC9057D7AFQ28387870-1D63B778-6A0C-4393-B659-488E53A33FD5Q28574756-98E5CB56-4BBE-46C5-A3B3-47DF320A17E3Q30277210-1156CEC0-8ED2-426C-B168-A400CABC6E96Q33303658-CEE25648-60C4-4A82-88A2-AFD16DE531C6Q33728236-8AD97800-976D-493D-87B1-1625CEB9DEC0Q33905579-0B094C25-ABFE-4DF2-9E17-AEEEF724631BQ35603440-B02236B1-D2D5-4959-A217-C87D2217097DQ35605251-4B743DD2-9920-4399-9CD3-E6088F118DFCQ35654399-ED9B584D-04C8-485E-8529-8FF27F08B6C9Q35883220-AEE0272D-5EA7-4402-BD67-E3160F7BDD0AQ36226235-2AA0AFA9-C7A1-4FFD-BB9C-8C90ED77EFF1Q36794724-8EF9A615-FDA2-45FC-ABC4-76BCA69A569AQ36807667-C0B51A3F-1B6D-4D67-9A42-44F8EF74279AQ37182555-AE403F0D-74E7-4C90-B4D8-3CF9CDFBAD95Q37213999-241998F4-FF24-458D-B431-29672AE54068Q37328804-CCD164D8-994F-4D4F-A933-A858473263A9Q37369915-0E63053A-D781-4465-80A9-FC616EAD57A4Q37463107-89A5B18B-41EF-4445-99E6-3BAAE0C431FBQ37929695-4D237066-4AC7-4174-AE84-BE623270E9C7Q38072272-FD06DA40-2E83-433D-A86F-6F32C2EBFF4DQ38310459-4035B1F1-3E33-4634-8CCE-17595DC7D285Q40162688-8DA8CC61-B434-4296-96B2-C7863B62945FQ40873441-9B3C7169-32AB-499A-94CC-5B6871124019Q40891751-DFCD38C4-67C8-4EF4-ACE1-4652E030B917Q41513949-2F186DAC-B5B0-4590-A84C-6E49EA15059AQ41583846-462B6E11-C06D-4153-B7F7-5FAB8563574DQ42221366-15122018-DFFE-4E3D-9CC7-DD93B61FEE63Q42981488-C08127A8-B493-448F-A957-695B4044A5BCQ44571323-0FA42B71-93EF-48D8-9076-DC83E295DC50Q46006782-97C70023-DF90-4061-9178-84EC6965A5D1Q46936805-424BB3B5-2622-4728-8D65-82F60B0FB0B3Q46982126-5E3EB5A1-69FF-4FD0-8166-725EC5F3D168Q47316702-845E01D9-D90C-45C8-898D-C476FE4C7842
P2860
Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia.
description
1990 nî lūn-bûn
@nan
1990 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@ast
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@en
type
label
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@ast
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@en
prefLabel
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@ast
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@en
P2093
P2860
P356
P1476
Evidence that down-regulation ...... use of diabetic hyperglycemia.
@en
P2093
C B Newgard
J H Johnson
M Ravazzola
R G Peterson
P2860
P304
P356
10.1073/PNAS.87.24.9953
P407
P577
1990-12-01T00:00:00Z